The outcomes and prognostic factors in patients with osteosarcoma according to age: a Japanese nationwide study with focusing on the age differences
Open Access
- 31 May 2018
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 18 (1) , 614
Abstract
Few reports have described clinical features, prognosis and prognostic factors of osteosarcoma patients according to age. Using the Bone and Soft Tissue Tumor Registry in Japan, we identified 1043 osteosarcoma patients including 760 who were younger than 40 years, 173 aged between 41 and 64 years, and 110 patients older than 65 years. We extracted data on patient demographics and prognosis. Prognostic factors for patients older than 65 years or other age groups were analyzed. Patients older than 65 years showed a significantly higher proportion of tumors arising in the trunk and with metastasis at diagnosis, and their 5-year disease-specific survival (DSS) rate was 32.7%. Multivariate analysis showed that the presence of metastasis at diagnosis [hazard ratio (HR): 3.04; 95% confidence interval (CI), 1.63–5.69; P < 0.001] and tumors > 16 cm in size (HR: 2.84 compared with < 8 cm; 95% CI, 1.16–6.97; P = 0.023) were significantly associated with worse DSS. The 5-year DSS was 39.1% in 80 patients older than 65 years without metastasis at diagnosis. Methotrexate was used in only 5.0% of these patients. Adjuvant chemotherapy was not significantly associated with better DSS (P = 0.323) in this generation and aged between 41 and 64 years (P = 0.566), although adjuvant chemotherapy yielded significantly better survival in patients younger than 40 years (P < 0.001). Analysis of this cohort of osteosarcoma patients revealed some unique clinical, therapeutic and prognostic features according to age groups in the largest cohort. Adjuvant chemotherapy was not associated with a better DSS in the group of patients aged between 41 and 64 years or older than 65 years.Keywords
Funding Information
- National Cancer Center Research and Development Fund (28-A-16)
This publication has 20 references indexed in Scilit:
- Development and external validation of nomograms predicting distant metastases and overall survival after neoadjuvant chemotherapy and surgery for patients with nonmetastatic osteosarcoma: A multi‐institutional studyCancer, 2015
- Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled TrialJournal of Clinical Oncology, 2015
- Japan as the front‐runner of super‐aged societies: Perspectives from medicine and medical care in JapanGeriatrics & Gerontology International, 2015
- Comorbidity in Adult Bone Sarcoma Patients: A Population-Based Cohort StudySarcoma, 2014
- Prognostic Factors in Elderly Osteosarcoma Patients: A Multi-institutional Retrospective Study of 86 CasesAnnals of Surgical Oncology, 2013
- Osteosarcoma in the elderly over 60 years: A multicenter study by the Japanese musculoskeletal oncology groupJournal of Surgical Oncology, 2009
- Osteosarcoma in Patients Older Than 65 YearsJournal of Clinical Oncology, 2008
- Osteosarcomas after the Age of 50: A Clinicopathologic Study of 64 Cases?an Experience in Northern JapanAnnals of Surgical Oncology, 2004
- Paget’s disease in New Zealand: evidence for declining prevalenceBone, 2002
- Low rates of Paget's disease of bone and osteosarcoma in elderly JapaneseThe Lancet, 1996